Literature DB >> 2109456

Asymptomatic homozygous protein C deficiency.

A Tripodi1, F Franchi, A Krachmalnicoff, P M Mannucci.   

Abstract

We report a family in which 2 homozygotes with similarly very low protein C levels have different clinical symptoms. One had recurrent venous thrombosis starting at the age of 28 years, the other is still asymptomatic at 38 years despite exposure to thrombotic risk factors. Our review of 13 additional cases reveals a highly variable phenotypic expression of homozygous protein C deficiency, which can be subdivided into two groups. In the first group are 8 kindreds in which homozygotes presented at birth with unmeasurable protein C levels and life-threatening thrombosis and 1 kindred in which homozygotes are characterized by very low levels of protein C but delayed onset (10 months of age) of thrombosis. In the second group are 4 kindreds characterized by very low, but measurable, protein C levels in homozygotes who survived beyond the neonatal period into adulthood with histories of moderately severe thrombosis. The present case demonstrates that protein C levels lower than 10% are compatible with a negative history for thrombosis, not only in the neonatal period but also during adulthood, and suggests that in some homozygotes other factors need to interact for full clinical penetrance of the defect.

Entities:  

Mesh:

Year:  1990        PMID: 2109456     DOI: 10.1159/000205194

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  7 in total

Review 1.  Inherited thrombophilia: memorandum from a joint WHO/International Society on Thrombosis and Haemostasis meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

2.  A delayed presentation of homozygous protein C deficiency in a series of children: a report on two molecular defects.

Authors:  Abdullah A Baothman; Enaam AlSobhi; Hassan A Khayat; Raed E Alsulami; Abdulaziz S Alkahtani; Abdelraheem A Al-Thobyani; Yousef I Marzouk; Mohammad A Abdelaal
Journal:  Clin Case Rep       Date:  2017-02-06

3.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 4.  Thrombophilia and the surgeon.

Authors:  E G Rhodes
Journal:  Ann R Coll Surg Engl       Date:  1996-07       Impact factor: 1.891

Review 5.  Coagulation abnormalities and cerebral infarction.

Authors:  M Greaves
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

6.  Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with thromboembolism and in the general population.

Authors:  Hee-Jin Kim; Ja-Young Seo; Ki-O Lee; Sung-Hwan Bang; Seung-Tae Lee; Chang-Seok Ki; Jong-Won Kim; Chul Won Jung; Duk-Kyung Kim; Sun-Hee Kim
Journal:  Haematologica       Date:  2013-10-25       Impact factor: 9.941

Review 7.  Genotypic and phenotypic character of Chinese neonates with congenital protein C deficiency: a case report and literature review.

Authors:  Xiaoying Li; Xiaoyan Li; Xiao Li; Yuanhua Zhuang; Lili Kang; Xiuli Ju
Journal:  Thromb J       Date:  2019-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.